Ali Amini Harandi

537 total citations
19 papers, 403 citations indexed

About

Ali Amini Harandi is a scholar working on Pathology and Forensic Medicine, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ali Amini Harandi has authored 19 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ali Amini Harandi's work include Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Systemic Lupus Erythematosus Research (3 papers). Ali Amini Harandi is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Systemic Lupus Erythematosus Research (3 papers). Ali Amini Harandi collaborates with scholars based in Iran, Syria and Canada. Ali Amini Harandi's co-authors include Mostafa Ghanei, Ali Sadeghinia, A Momeni, Gita Faghihi, Ali Asilian, Hossein Pakdaman, Mohammad Ali Sahraian, Payman Salamati, Seyed‐Mohammad Fereshtehnejad and Mehdi Abbasi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Immunological Methods.

In The Last Decade

Ali Amini Harandi

19 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Amini Harandi Iran 11 120 99 83 72 52 19 403
Shahryar Pourfarzam Iran 12 206 1.7× 25 0.3× 60 0.7× 75 1.0× 63 1.2× 30 391
Maria Cristina Colanardi Italy 15 48 0.4× 105 1.1× 108 1.3× 59 0.8× 27 0.5× 30 738
Mili Thakur United States 13 24 0.2× 58 0.6× 242 2.9× 120 1.7× 19 0.4× 46 651
İjlal Erturan Türkiye 11 19 0.2× 37 0.4× 43 0.5× 90 1.3× 18 0.3× 37 390
Dagmar-Ulrike Richter Germany 18 23 0.2× 60 0.6× 86 1.0× 184 2.6× 39 0.8× 36 595
T. C. Iancu Israel 14 28 0.2× 25 0.3× 25 0.3× 110 1.5× 33 0.6× 34 516
Guicheng Wu China 11 43 0.4× 34 0.3× 8 0.1× 193 2.7× 28 0.5× 39 516
S.M. Keller United States 11 127 1.1× 60 0.6× 77 0.9× 95 1.3× 319 6.1× 30 725
M Shirahama Japan 13 16 0.1× 17 0.2× 28 0.3× 48 0.7× 56 1.1× 32 514
Natascha Schweighofer Austria 14 13 0.1× 157 1.6× 189 2.3× 225 3.1× 16 0.3× 35 803

Countries citing papers authored by Ali Amini Harandi

Since Specialization
Citations

This map shows the geographic impact of Ali Amini Harandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Amini Harandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Amini Harandi more than expected).

Fields of papers citing papers by Ali Amini Harandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Amini Harandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Amini Harandi. The network helps show where Ali Amini Harandi may publish in the future.

Co-authorship network of co-authors of Ali Amini Harandi

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Amini Harandi. A scholar is included among the top collaborators of Ali Amini Harandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Amini Harandi. Ali Amini Harandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Harandi, Ali Amini, et al.. (2022). Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis. NeuroImmunoModulation. 29(4). 476–485. 9 indexed citations
2.
Pakdaman, Hossein, et al.. (2018). A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis. Neurological Sciences. 39(12). 2107–2113. 6 indexed citations
3.
Harandi, Ali Amini, et al.. (2018). Balo’s concentric sclerosis: an update and comprehensive literature review. Reviews in the Neurosciences. 29(8). 873–882. 13 indexed citations
4.
Razavi, Seyed Mohammad, Payman Salamati, Ali Amini Harandi, & Mostafa Ghanei. (2013). Prevention and Treatment of Respiratory Consequences Induced by Sulfur Mustard in Iranian Casualties. SHILAP Revista de lepidopterología. 6 indexed citations
5.
Salamati, Payman, et al.. (2013). Prevention and treatment of respiratory consequences induced by sulfur mustard in Iranian casualties.. PubMed. 4(4). 383–9. 19 indexed citations
6.
Harandi, Ali Amini, et al.. (2012). Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.. PubMed. 11(2). 54–8. 27 indexed citations
7.
Harandi, Ali Amini, et al.. (2012). Infectious Diseases, Related Vaccinations, and Risk of Multiple Sclerosis Later in Life: A Case-Control Study (P03.242). Neurology. 78(Meeting Abstracts 1). P03.242–P03.242. 1 indexed citations
8.
Harandi, Ali Amini, et al.. (2012). Serum prolactin level in patients with relapsing–remitting multiple sclerosis during relapse. Journal of Clinical Neuroscience. 19(4). 622–623. 16 indexed citations
9.
10.
Sahraian, Mohammad Ali, Hossein Pakdaman, & Ali Amini Harandi. (2012). Is it time to revise the classification of geographical distribution of multiple sclerosis?. PubMed. 11(2). 77–8. 12 indexed citations
11.
Harandi, Ali Amini, et al.. (2012). Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis.. PubMed. 11(3). 118–20. 6 indexed citations
12.
Harandi, Ali Amini, et al.. (2012). Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge. SHILAP Revista de lepidopterología. 2012. 1–5. 10 indexed citations
13.
Mohebbi, Alireza, et al.. (2011). Rare Presentation of Rhino-Orbital-Cerebral Zygomycosis: Bilateral Facial Nerve Palsy. Case Reports in Medicine. 2011. 1–2. 6 indexed citations
14.
Harandi, Ali Amini, et al.. (2011). Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin. SHILAP Revista de lepidopterología. 2011. 1–4. 20 indexed citations
15.
Harandi, Ali Amini, et al.. (2011). HLA allele frequencies in Iranian opticospinal multiple sclerosis patients<br>——HLA in Opticospinal MS. Journal of Biomedical Science and Engineering. 4(7). 511–515. 2 indexed citations
16.
Ghanei, Mostafa, et al.. (2010). Effect of TGFß1 and TIMP2 on disease activity in asthma and COPD.. PubMed. 9(2). 79–86. 10 indexed citations
17.
Ghanei, Mostafa & Ali Amini Harandi. (2007). Long Term Consequences from Exposure to Sulfur Mustard: A Review. Inhalation Toxicology. 19(5). 451–456. 156 indexed citations
18.
Harandi, Ali Amini, et al.. (2007). Doxycycline: A Pilot Study to Reduce Diabetic Proteinuria. American Journal of Nephrology. 27(3). 269–273. 16 indexed citations
19.
Asilian, Ali, Ali Sadeghinia, Gita Faghihi, A Momeni, & Ali Amini Harandi. (2003). The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. Annals of Tropical Medicine and Parasitology. 97(5). 493–498. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shahryar Pourfarzam Breakdown of academic impact, for papers by Maria Cristina Colanardi Breakdown of academic impact, for papers by Mili Thakur Breakdown of academic impact, for papers by İjlal Erturan Breakdown of academic impact, for papers by Dagmar-Ulrike Richter Breakdown of academic impact, for papers by T. C. Iancu Breakdown of academic impact, for papers by Guicheng Wu Breakdown of academic impact, for papers by S.M. Keller Breakdown of academic impact, for papers by M Shirahama Breakdown of academic impact, for papers by Natascha Schweighofer
Rankless by CCL
2026